Johnson & Johnson says offered $2.1 billion for LifeScan diabetes unit

(Reuters) - Johnson & Johnson has been offered about $2.1 billion for its LifeScan Inc unit, which makes blood glucose monitoring products, by private investment firm Platinum Equity, the healthcare company said on Friday.

Johnson & Johnson says offered $2.1 billion for LifeScan diabetes unit
Read More


Bagikan Berita Ini